Literature DB >> 10072601

Centrosome amplification as a possible mechanism for numerical chromosome aberrations in cerebral primitive neuroectodermal tumors with TP53 mutations.

R G Weber1, J M Bridger, A Benner, D Weisenberger, V Ehemann, G Reifenberger, P Lichter.   

Abstract

Although alterations in chromosome number have frequently been detected in human tumor cells and associated with tumor initiation and progression, the causal mechanisms are still not understood. One protein known to be involved in maintaining genetic stability is tumor suppressor p53. In mice, p53 has been implicated in the maintenance of diploidy (Cross et al., 1995) and the regulation of centrosome duplication (Fukasawa et al., 1996). Here we report on cerebral primitive neuroectodermal tumors that lacked the wild-type p53 gene (TP53) and showed multiple numerical chromosome aberrations, as detected by comparative genomic hybridization. In these tumors, the centrosome number was significantly higher than in a control tumor without a detected TP53 mutation and with few chromosomal imbalances. These findings indicate that abnormal centrosome amplification can occur in human tumors lacking wild-type TP53 and may be a mechanism by which numerical chromosome aberrations are generated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10072601     DOI: 10.1159/000015168

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  16 in total

1.  Altered centrosome structure is associated with abnormal mitoses in human breast tumors.

Authors:  W L Lingle; J L Salisbury
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 2.  Links between mutant p53 and genomic instability.

Authors:  Walter Hanel; Ute M Moll
Journal:  J Cell Biochem       Date:  2012-02       Impact factor: 4.429

3.  Characterization of Su48, a centrosome protein essential for cell division.

Authors:  Qiang Wang; Xiulian Du; Judy Meinkoth; Yoshihiko Hirohashi; Hongtao Zhang; Qingdu Liu; Mark Richter; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

4.  The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability.

Authors:  Antonietta Rosella Farina; Antonella Tacconelli; Lucia Cappabianca; Gesilia Cea; Sonia Panella; Antonella Chioda; Alessandra Romanelli; Carlo Pedone; Alberto Gulino; Andrew Reay Mackay
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

Review 5.  Aberrant activation of cell cycle regulators, centrosome amplification, and mitotic defects.

Authors:  Kenji Fukasawa
Journal:  Horm Cancer       Date:  2011-04       Impact factor: 3.869

6.  Results of buccal micronucleus cytome assay in pesticide-exposed and non-exposed group.

Authors:  Hayal Cobanoglu; Munevver Coskun; Mahmut Coskun; Akin Çayir
Journal:  Environ Sci Pollut Res Int       Date:  2019-05-11       Impact factor: 4.223

7.  Krüppel-like factor 4 prevents centrosome amplification following gamma-irradiation-induced DNA damage.

Authors:  Hong S Yoon; Amr M Ghaleb; Mandayam O Nandan; Irfan M Hisamuddin; William Brian Dalton; Vincent W Yang
Journal:  Oncogene       Date:  2005-06-09       Impact factor: 9.867

8.  Chromosomal aberrations in PARP(-/-) mice: genome stabilization in immortalized cells by reintroduction of poly(ADP-ribose) polymerase cDNA.

Authors:  C M Simbulan-Rosenthal; B R Haddad; D S Rosenthal; Z Weaver; A Coleman; R Luo; H M Young; Z Q Wang; T Ried; M E Smulson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 9.  Centrosome amplification and the origin of chromosomal instability in breast cancer.

Authors:  Jeffrey L Salisbury; Antonino B D'Assoro; Wilma L Lingle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

10.  The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1.

Authors:  Jian Du; Gregory J Hannon
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.